Italia markets closed

BMY Jan 2026 33.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,79000,0000 (0,00%)
Alla chiusura: 12:51PM EDT
Schermo intero
Chiusura precedente1,7900
Aperto1,7900
Denaro1,5200
Lettera2,0400
Prezzo d'esercizio33,00
Scadenza2026-01-16
Min-Max giorno1,7900 - 1,7900
Contratto - Min-MaxN/D
Volume1
Open Interest149
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri